WASHINGTON - ESI Lederle announced last Thursday that it was recalling 4.2 million capsules of the arthritis drug etodolac because of contamination that could cause life-threatening complications in patients with heart conditions.
The company said that the recall will cover one lot of 300-milligram capsules, No. 9991052, which were distributed nationwide. For more information visit www.fda.gov.
